Press Releases about Atai Life Sciences N.V.
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
November 10, 2022
From atai Life Sciences
Via GlobeNewswire
Women in Psychedelics Announces atai as Platinum Sponsors
November 04, 2022
Via Business Wire
atai Life Sciences Announces R&D Day Agenda
October 20, 2022
From atai Life Sciences
Via GlobeNewswire
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Via PressReach
Topics
Supply Chain
Exposures
Supply Chain
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Via PressReach
Topics
Cannabis
Exposures
Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Topics
Cannabis
Exposures
Cannabis
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Psychedelics Use Among Young Adults Reaches All-Time High
September 01, 2022
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
Topics
Supply Chain
Exposures
Supply Chain
Topics
Derivatives
Exposures
Derivatives
Topics
Law Enforcement
Exposures
Legal
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.